Table 1 Demographic characteristics and cardiopulmonary comorbidities of enrolled participants
LPLC group (n = 62) | SPLC group (n = 62) | P value§ | |
|---|---|---|---|
Age (y) * | 61.9(8.1) | 64.9(8.4) | 0.059& |
Sex | 0.857 | ||
Female | 33(53.2%) | 34(54.8%) | |
Male | 29(46.8%) | 28(45.2%) | |
BMI (kg/m2) * | 24.4(3.4) | 25.1(3.9) | 0.290& |
ASA classification | 0.794 | ||
I | 8(12.9) | 9(14.5) | |
II or higher | 54(87.1) | 53(85.5) | |
Preoperative laboratory results | |||
Count of white blood cell (×109/L) † | 5.97(3.03–21.98) | 6.11(2.48–17.97) | 0.840# |
Hemoglobin (g/L) † | 137.7(75–174) | 138.0(110–165) | 0.289# |
Thrombocyte (×109/L) † | 209.5(126–466) | 215.5(95–514) | 0.736# |
Albumin (g/L) † | 41.8(27–48) | 42.3(32–49) | 0.689# |
Alanine aminotransferase (IU/L) † | 20.95(6-358) | 42.34(8-448) | 0.252# |
Serum creatinine (mmol/L) † | 68.7(45–127) | 65.7(35–108) | 0.944# |
Cardiopulmonary Comorbidities | |||
Hypertension | 26(41.9%) | 31(50.0%) | 0.368 |
Diabetes mellitus | 13(21.0%) | 13(21.0%) | 1.000 |
Coronary heart disease | 8(12.9%) | 17(27.4%) | 0.044 |
Arrhythmia | 5(8.10%) | 7(11.3%) | 0.544 |
Pulmonary emphysema | 8(12.9%) | 10(16.1%) | 0.610 |
Chronic bronchitis | 3(4.8%) | 5(8.1%) | 0.717¶ |
Bronchial asthma | 3(4.8%) | 2(3.2%) | 1.000¶ |
History of pulmonary surgery | 1(1.6%) | 1(1.6%) | 1.000¶ |
History of cardiac or mediastinal surgery | 0(0) | 2(3.2%) | 0.496¶ |
Smoking>5 years | 9(14.5%) | 6(9.7%) | 0.409¶ |
Liver cirrhosis | 1(1.6%) | 0(0) | 1.000¶ |
History of biliary inflammation or biliary pancreatitis | 30(48.4%) | 14(22.6%) | 0.003¶ |
History of PTCD | 1(1.6%) | 1(1.6%) | 1.000¶ |
History of ERCP | 3(4.8%) | 1(1.6%) | 0.619¶ |